» Articles » PMID: 20150357

Untreated Poor Vision: a Contributing Factor to Late-life Dementia

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2010 Feb 13
PMID 20150357
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Ophthalmologic abnormalities have been described in patients with dementia, but the extent to which poor vision and treatment for visual disorders affect cognitive decline is not well defined. Linked data from the Health and Retirement Study and Medicare files (1992-2005) were used to follow the experiences of 625 elderly US study participants with normal cognition at baseline. The outcome was a diagnosis of dementia, cognitively impaired but no dementia, or normal cognition. Poor vision was associated with development of dementia (P = 0.0048); individuals with very good or excellent vision at baseline had a 63% reduced risk of dementia (95% confidence interval (CI): 20, 82) over a mean follow-up period of 8.5 years. Participants with poorer vision who did not visit an ophthalmologist had a 9.5-fold increased risk of Alzheimer disease (95% CI: 2.3, 39.5) and a 5-fold increased risk of cognitively impaired but no dementia (95% CI: 1.6, 15.9). Poorer vision without a previous eye procedure increased the risk of Alzheimer disease 5-fold (95% CI: 1.5, 18.8). For Americans aged 90 years or older, 77.9% who maintained normal cognition had received at least one previous eye procedure compared with 51.7% of those with Alzheimer disease. Untreated poor vision is associated with cognitive decline, particularly Alzheimer disease.

Citing Articles

The implementation and effectiveness of Integrated Psychological Therapy (IPT) in chronic middle-aged inpatients with schizophrenia.

Poulou A, Anagnostopoulos F, Vatakis A, Mellon R, Mueller D Schizophr Res Cogn. 2024; 39:100330.

PMID: 39355202 PMC: 11439836. DOI: 10.1016/j.scog.2024.100330.


Cross-sectional study of cognitive impairment and visual impairment among the elderly population in residential care in India: the Hyderabad Ocular Morbidity in Elderly Study (HOMES).

Marmamula S, Kumbham T, Ehrlich J, Alladi S, Bloom D, Friedman D BMJ Open. 2024; 14(7):e084348.

PMID: 39038860 PMC: 11407191. DOI: 10.1136/bmjopen-2024-084348.


Impact of Social Vulnerability Index on the Development of Severe Visual Impairment or Blindness From Glaucoma.

Swaminathan S, Medeiros F, Gedde S Am J Ophthalmol. 2024; 267:172-181.

PMID: 38971319 PMC: 11486566. DOI: 10.1016/j.ajo.2024.06.024.


Exploring the link between comorbidities and Alzheimer's dementia in the Australian Imaging, Biomarker & Lifestyle (AIBL) study.

Nguyen C, Ma L, Low Y, Tan E, Fowler C, Masters C Alzheimers Dement (Amst). 2024; 16(2):e12593.

PMID: 38770381 PMC: 11103763. DOI: 10.1002/dad2.12593.


The Association of Vision and Hearing Impairment on Cognitive Function and Loneliness: Evidence From the Mexican Health and Aging Study.

Hreha K, Samper-Ternent R, Whitson H, Downer L, West J, Downer B J Aging Health. 2024; :8982643241247583.

PMID: 38621720 PMC: 11473705. DOI: 10.1177/08982643241247583.


References
1.
Cronin-Golomb A, Corkin S, Growdon J . Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optom Vis Sci. 1995; 72(3):168-76. DOI: 10.1097/00006324-199503000-00004. View

2.
Ding J, Patton N, Deary I, Strachan M, Fowkes F, Mitchell R . Retinal microvascular abnormalities and cognitive dysfunction: a systematic review. Br J Ophthalmol. 2008; 92(8):1017-25. DOI: 10.1136/bjo.2008.141994. View

3.
Barber M, Stott D . Validity of the Telephone Interview for Cognitive Status (TICS) in post-stroke subjects. Int J Geriatr Psychiatry. 2004; 19(1):75-9. DOI: 10.1002/gps.1041. View

4.
Bennett D, Schneider J, Tang Y, Arnold S, Wilson R . The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 2006; 5(5):406-12. DOI: 10.1016/S1474-4422(06)70417-3. View

5.
Crooks V, Clark L, Petitti D, Chui H, Chiu V . Validation of multi-stage telephone-based identification of cognitive impairment and dementia. BMC Neurol. 2005; 5(1):8. PMC: 1090587. DOI: 10.1186/1471-2377-5-8. View